MNEMO THERAPEUTICS
Registro de marca em vigor (Madri)
Marca Mista depositada no INPI em
14/09/2021 por MNEMO THERAPEUTICS,
processo nº 501638161, nas classes 01, 05, 10, 40, 42, 44.
Registro em vigor até 14/09/2031.
| Número do processo | 501638161 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Mista |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 14/09/2021 |
|---|
| Data da concessão | 17/10/2023 |
|---|
| Vigência até | 14/09/2031 |
|---|
| Titular | MNEMO THERAPEUTICS |
|---|
| UF · País | — · FR |
Classes e especificação
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions.;
Pharmaceutical products; biological and pharmaceutical preparations; biological and pharmaceutical preparations for the treatment of cancer and tumors using immunotherapy; preparing therapeutic solutions, namely, antigen, antibodies, T-cells; biological materials, preparations, reagents for products for medical use; antigens, antibodies, cells for therapeutic use.;
Medical apparatus and instruments; apparatus and instruments for carrying out tests and diagnostics for medical use; apparatus and instruments for identifying, screening, analyzing and developing antigens for medical use; medical apparatus for reading of analytical tests.;
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacturing antigens, antibodies, T-cells; providing information in the field of manufacturing pharmaceuticals.;
Scientific research services for medical purposes; services for identifying, screening and developing antigens; scientific and technological services; scientific laboratory services; providing scientific and medical information with regard to immunotherapy; providing services for the identification, analysis, authentication, purification and development of biological material from a genomic platform; epigenetic antigen identification and screening services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; services of computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; services of a computer software platform enabling the use of algorithms for predicting the characteristics of antigens and immunological responses.;
Providing medical information with regard to immunotherapy.;